31.12.2023
At the end of 2023, GOTECH Antimicrobial secured exclusive commercialization rights to the technology behind GOcap®. Through a licensing agreement with INEB/i3S and U.Porto, the company strengthened its position for investor engagement and the upcoming clinical rollout of GOcap®.